BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 19847204)

  • 1. Mechanisms controlling titer and expression of bidirectional lentiviral and gammaretroviral vectors.
    Maetzig T; Galla M; Brugman MH; Loew R; Baum C; Schambach A
    Gene Ther; 2010 Mar; 17(3):400-11. PubMed ID: 19847204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equal potency of gammaretroviral and lentiviral SIN vectors for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells.
    Schambach A; Bohne J; Chandra S; Will E; Margison GP; Williams DA; Baum C
    Mol Ther; 2006 Feb; 13(2):391-400. PubMed ID: 16226060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods.
    Sastry L; Johnson T; Hobson MJ; Smucker B; Cornetta K
    Gene Ther; 2002 Sep; 9(17):1155-62. PubMed ID: 12170379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rev/RRE-independent Mason-Pfizer monkey virus constitutive transport element-dependent propagation of SIVmac239 vectors using a single round of replication assay.
    Rizvi TA; Schmidt RD; Lew KA; Keeling ME
    Virology; 1996 Aug; 222(2):457-63. PubMed ID: 8806531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions.
    ter Brake O; Berkhout B
    J Gene Med; 2007 Sep; 9(9):743-50. PubMed ID: 17628029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective lentiviral vectors are efficiently trafficked by HIV-1 and inhibit its replication.
    Klimatcheva E; Planelles V; Day SL; Fulreader F; Renda MJ; Rosenblatt J
    Mol Ther; 2001 Jun; 3(6):928-39. PubMed ID: 11407907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multigene lentiviral vectors based on differential splicing and translational control.
    Zhu Y; Feuer G; Day SL; Wrzesinski S; Planelles V
    Mol Ther; 2001 Oct; 4(4):375-82. PubMed ID: 11592842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
    Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
    J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lentiviral vector design using alternative RNA export elements.
    Oh T; Bajwa A; Jia G; Park F
    Retrovirology; 2007 Jun; 4():38. PubMed ID: 17550606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stabilization of gammaretroviral and lentiviral vectors: from production to gene transfer.
    Carmo M; Alves A; Rodrigues AF; Coroadinha AS; Carrondo MJ; Alves PM; Cruz PE
    J Gene Med; 2009 Aug; 11(8):670-8. PubMed ID: 19507176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming promoter competition in packaging cells improves production of self-inactivating retroviral vectors.
    Schambach A; Mueller D; Galla M; Verstegen MM; Wagemaker G; Loew R; Baum C; Bohne J
    Gene Ther; 2006 Nov; 13(21):1524-33. PubMed ID: 16763662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene transfer system derived from the caprine arthritis-encephalitis lentivirus.
    Mselli-Lakhal L; Guiguen F; Greenland T; Mornex JF; Chebloune Y
    J Virol Methods; 2006 Sep; 136(1-2):177-84. PubMed ID: 16797087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lentiviral vectors for enhanced gene expression in human hematopoietic cells.
    Ramezani A; Hawley TS; Hawley RG
    Mol Ther; 2000 Nov; 2(5):458-69. PubMed ID: 11082319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tight control of transgene expression by lentivirus vectors containing second-generation tetracycline-responsive promoters.
    Pluta K; Luce MJ; Bao L; Agha-Mohammadi S; Reiser J
    J Gene Med; 2005 Jun; 7(6):803-17. PubMed ID: 15655804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous targeting of HCV replication and viral binding with a single lentiviral vector containing multiple RNA interference expression cassettes.
    Henry SD; van der Wegen P; Metselaar HJ; Tilanus HW; Scholte BJ; van der Laan LJ
    Mol Ther; 2006 Oct; 14(4):485-93. PubMed ID: 16872906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A bicistronic SIN-lentiviral vector containing G156A MGMT allows selection and metabolic correction of hematopoietic protoporphyric cell lines.
    Richard E; GĂ©ronimi F; Lalanne M; Ged C; Redonnet-Vernhet I; Lamrissi-Garcia I; Gerson SL; de Verneuil H; Moreau-Gaudry F
    J Gene Med; 2003 Sep; 5(9):737-47. PubMed ID: 12950064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoregulated, bidirectional and multicistronic gas-inducible mammalian as well as lentiviral expression vectors.
    Hartenbach S; Fussenegger M
    J Biotechnol; 2005 Oct; 120(1):83-98. PubMed ID: 16026881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the relative level of gene expression from different retroviral vectors used for gene therapy.
    Byun J; Kim SH; Kim JM; Yu SS; Robbins PD; Yim J; Kim S
    Gene Ther; 1996 Sep; 3(9):780-8. PubMed ID: 8875226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bidirectional promoter interference between two widely used internal heterologous promoters in a late-generation lentiviral construct.
    Curtin JA; Dane AP; Swanson A; Alexander IE; Ginn SL
    Gene Ther; 2008 Mar; 15(5):384-90. PubMed ID: 18283290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of lentiviral vectors by transient expression of minimal packaging genes from recombinant adenoviruses.
    Kuate S; Stefanou D; Hoffmann D; Wildner O; Uberla K
    J Gene Med; 2004 Nov; 6(11):1197-205. PubMed ID: 15459964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.